Inactive Instrument

Highlights Mallinckrodt plc

Equities

MNK

IE000O3L0NQ3

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Mallinckrodt plc Reaffirms Financial Guidance for the Full Year of 2024	05-09	CI
Mallinckrodt plc Reports Earnings Results for the Full Year Ended December 29, 2023	03-26	CI
Mallinckrodt plc Reports Earnings Results for the Fourth Quarter Ended December 29, 2023	03-26	CI
Mallinckrodt plc Provides Earnings Guidance for the Year 2024	03-26	CI
Mallinckrodt plc Announces FDA Clearance of the INOmax® EVOLVE? DS Delivery System and Approval of the INOmax® Mini-Cylinder	12-07	CI
Mallinckrodt plc to Present Breadth of Data on Terlivaz (Terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome At the American Association for the Study of Liver Diseases 2023 Liver Meeting	11-08	CI
Mallinckrodt plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 29, 2023	11-07	CI
Mallinckrodt plc Revises Earnings Guidance for the Full-Year of 2023	11-07	CI
Mallinckrodt Presents Latest Health Economics Data on Acthar Gel (Repository Corticotropin Injection) At the Academy of Managed Care Pharmacy Nexus 2023	26/10/23	CI
Rite Aid joins companies going bankrupt amid opioid litigation	16/10/23	RE
Drug retailer Rite Aid files for bankruptcy, gets $3.45 bln commitment	16/10/23	RE
News Highlights : Top Company News of the Day	11/10/23	DJ
Mallinckrodt gets court approval for restructuring, $1 bln cut to opioid settlement	10/10/23	RE
MALLINCKRODT GETS COURT APPROVAL FOR RESTRUCTURING, $1 BLN CUT T…	10/10/23	RE
Mallinckrodt Announces Publication of Two Journal Manuscripts with Clinical and Economic Evidence for Acthar Gel (Repository Corticotropin Injection)	10/10/23	CI
Mallinckrodt Reportedly Considers Sale of Opioid Business	17/09/23	CI
Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse	31/08/23	RE
Mallinckrodt plc Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder	31/08/23	CI
Drugmaker Mallinckrodt files for second bankruptcy in the US	28/08/23	RE
Earnings Flash (MNK) MALLINCKRODT Reports Q2 Revenue $475M	09/08/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Mallinckrodt plc

Equities

MNK

IE000O3L0NQ3

Highlights

Filters